Role, benefits, and risks of AMH testing for non-ART related indications
The March ESHRE Journal Club discussion focused on a study by Copp et al. (2023) on the advantages and disadvantages of AMH testing, the misinterpretation of AMH levels outside an infertility treatment, the variability of AMH levels in different populations, and the impact of misleading media portrayal of DTC AMH tests on consumers.AMH, Anti-M ullerian hormone; DTC, direct-to-consumer.
Authors
- Juan J Fraire-Zamora (ORCID: https://orcid.org/0000-0003-2870-0140)
- Antonio La Marca (ORCID: https://orcid.org/0000-0001-7921-9547)
- Omar Farhan Ammar (ORCID: https://orcid.org/0000-0001-8048-9747)
- George Liperis (ORCID: https://orcid.org/0000-0001-9588-3392)
- Julia Uraji (ORCID: https://orcid.org/0000-0002-1441-4074)
- M Mincheva (ORCID: https://orcid.org/0000-0003-2917-2546)
- Raj Mathur (ORCID: https://orcid.org/0000-0002-7550-1817)
- Claudia Massarotti (ORCID: https://orcid.org/0000-0003-1905-2786)
- Zoya Enakshi Ali (ORCID: https://orcid.org/0000-0002-2659-0585)
- Helen C. O’Neill (ORCID: https://orcid.org/0000-0003-3481-3459)
- Mariana Moura-Ramos
Institutions
- University of Modena and Reggio Emilia (IT)
- The University of Sydney (AU)
- University of Anbar (IQ)
- Larnaca College (CY)
- Institute of Reproductive Medicine (IN)
- Westmead Institute (AU)
- Women's Health Research Institute (CA)
- Ospedale Policlinico San Martino (IT)
- St Mary's Hospital (AU)
- Cognitive Research (United States) (US)
- University College London (GB)
- University of Coimbra (PT)
- University of Genoa (IT)
Publication Details
- Journal
- Human Reproduction
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1093/humrep/deae234
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Society of Human Reproduction and Embryology